ARTICLE | Company News
Orphan Technologies, St. George's University deal
February 11, 2013 8:00 AM UTC
The university granted Orphan Technologies exclusive, worldwide rights to preclinical enzyme replacement therapies (ERTs) OT-15 and OT-81. OT-15, or Erythrocyte Encapsulated Thymidine Phosphorylase (E...